HomeINNO • CNSX
add
Innocan Pharma Corp
Previous close
$6.66
Year range
$5.76 - $21.00
Market cap
29.94M CAD
Avg Volume
1.21K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 4.99M | -7.65% |
Operating expense | 5.35M | 0.45% |
Net income | 2.00M | 1,850.00% |
Net profit margin | 40.00 | 1,995.73% |
Earnings per share | — | — |
EBITDA | -910.00K | 0.33% |
Effective tax rate | -16.45% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.69M | 33.53% |
Total assets | 10.52M | 13.63% |
Total liabilities | 2.28M | 2.10% |
Total equity | 8.24M | — |
Shares outstanding | 4.48M | — |
Price to book | 5.33 | — |
Return on assets | -21.30% | — |
Return on capital | -26.61% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 2.00M | 1,850.00% |
Cash from operations | -581.00K | -15.28% |
Cash from investing | -5.00K | -107.69% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -583.00K | -1,089.80% |
Free cash flow | -3.89M | -745.87% |
About
Founded
2017
Website
Employees
8
